lower fair valu reflect advers
page full analyst note apr
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research apr
estim
price data apr
rate updat apr
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
intern flavor fragranc global leader flavor
fragranc industri roughli share billion
industri competitor givaudan firmenich
symris big four flavor fragranc compani
command roughli combin three fourth global market share
product impart desir tast smell feel base
custom specif custom primarili oper food
beverag person care industri
segment -- tast scent -- contribut equal
margin therefor gener modestli larger share profit
versu fragranc compani oper third segment
complet acquisit frutarom octob
addit announc merger dupont nutrit
bioscienc busi transform deal would
doubl enterpris valu transact expect
close end first-quart
global footprint help land suppli agreement
larg global consum packag good compani half sale
direct custom global presenc half
custom region presenc compani sale split
equal emerg develop economi
proprietari formul key driver revenu growth
exampl rather suppli basic flavor solut sweet
spot suppli innov solut modul consum
experi help save cost custom provid
fine-tun flavor agent allow use cheaper
ingredi extend product shelf life addit
fat sugar sodium product without sacrif
forecast modest margin expans legaci busi
come year product mix improv compani
product program announc februari drive materi
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
intern flavor fragranc produc flavor fragranc food
beverag household good person care make proprietari
formul partner custom deliv custom solut
mid-cycle environ compani deriv roughli sale
tast segment scent segment
frutarom along givaudan firmenich symris
flavor fragranc one big four flavor fragranc compani
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
lower fair valu reflect advers
updat valuat model intern
flavor fragranc sensient technolog reflect
impact outbreak lower
fair valu estim fair valu estim fall
per share sensient fair valu
estim fall per share compani
fair valu reduct stem temper near-term
profit expect well downward adjust
assum termin ev/ebitda multipl clear
downward multipl adjust entir unrel
outbreak admittedli like overdu
although retain wide moat sensient maintain
narrow moat compani moat appear
narrow recent year
even market appear sour
compani prospect far current
share price stock offer attract risk-adjust
upsid updat fair valu estim trade
star territori sensient territori although
neither immun advers impact
outbreak contend insul
compani cover due healthi exposur custom
consum stapl sector addit
compani combin switch cost intang
asset decreas
likelihood cash-strap
custom abl switch cheaper altern
inde would risk
percept product
less favor long-term outlook stem
view frutarom integr partial dilut
moati firm legaci asset base furthermor
frutarom asset perform far wors iff
manag team expect accordingli
believ iff termin ev/ebitda multipl belong
peer givaudan symris weve lower
time howev reassess
compani econom moat rate integr
dupont nutrit bioscienc divis near although
asset appear moati
estim indic overpaid acquir
assert overpaid acquir frutarom
restructur
weve decreas sensient termin multipl time
engag major restructur effort
oper short optim effort indic
less competitively-advantag portfolio
previous assum fact base case assumpt
reflect return invest capit includ goodwil
slightli compani cost capit
case howev expect compani
restor econom profit gener rel wide
margin safeti cours explicit forecast
fair valu estim per share
flavor fragranc gener modest organ
sale growth recent year consider chunk
increment revenu deriv acquisit forecast
compound annual growth rate sale
assum organ growth frutarom
fulli integr forecast mid-cycle adjust oper
incom billion sale billion
forecast sit roughli line compani trail
exit multipl discount cash flow model
time enterpris value/ebitda slightli intern
flavor fragranc trail averag base
cost equiti cost debt appli
weight averag cost capit
frutarom acquir believ lofti deal
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
enterpris valu adjust model
financi statement continu reflect stand-alon
busi without contribut dupont asset
slate merg
intern flavor fragranc subject low
uncertainti reflect narrow rang outcom
repres bull- bear-cas scenario
bear-cas scenario assum organ companywid
sale roughli annual
bear-cas mid-cycle adjust oper margin
bear case assum million penalti
associ improp payment conduct frutarom
oper russia ukrain higher million
assum base case even penalti magnitud
minim impact fair valu estim
scenario produc fair valu estim per share
bull scenario assum companywid sale
grow roughli annual rate adjust oper
margin expand mid-cycle level bull case
assum impact cash flow frutarom
misconduct scenario produc fair valu estim
assign wide moat rate intern flavor
fragranc appropri len
analyz compani competit advantag moat
framework commod processor moati busi
oper space tend benefit switch
cost intang asset cost advantag howev
cite intang asset switch cost
compani highli valuabl intang asset form
switch cost help ensur durabl econom
profit gener intend review econom moat
price initi profit result soft addit
model assum small million settlement
paid associ improp payment made
frutarom oper russia ukrain
million amount roughli line median fcpa
violat payment made -list compani across
violat given affect sale
repres less combin frutarom
revenu larg penalti seem unlik
current valuat model assum
merger dupont nutrit health busi
prove value-destruct tune roughli million
per share figur far larger
deal announc influenc fact
assumpt legaci oper underli
enterpris valu sinc declin make
exchang transfer share dupont sharehold
attract sharehold
previous even though still view deal
dupont asset
attract price paid appear steep synergi
target lofti transact current account via
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
rate compani propos merger dupont
nutrit bioscienc unit close expect earli
intang asset stem spend requir
develop highli engin proprietari
formul cant precis replic although
custom outlin specif flavor fragranc profil
look achiev result intellectu
properti develop intern flavor fragranc
stay compani establish valuabl
intang asset allow gener econom profit
life cycl product proprietari
formul use like givaudan symris
wide-moat competitor cover spend
account sale substanti
spend ensur compani pipelin proprietari
formul remain strong help compani stay
ahead curv identifi servic new custom
trend grant patent
 sinc develop custom molecul
deliveri system specif custom
widespread accept custom core list serv
compani increasingli mid-size compani use core
list flavor fragranc supplier core list
select list typic two four author supplier
supplier core list
opportun bid compani busi reduc
overal competit intens top four flavor
fragranc compani truli global oper
mean competit multi-national custom larg
limit alon small compani prevent
compet larger custom unabl
achiev suffici scale match invest
thu innov capabl top flavor
evid switch cost support fact
volum repres specialti solut rather
fragranc manufactur custom solut food
beverag person care household product industri
provid special tast textur aroma profil
wide varieti consum product custom
switch supplier would risk lose highli specif
characterist provid product potenti
impair brand equiti particularli riski
proposit mani cpg compani given substanti
amount capit invest build
market brand concern combin
fact solut account small portion
custom unit cost product less
typic lead sticki busi relationship
custom select specif tast textur aroma solut
gener unwil switch supplier basi
cost alon research ac nielsen indic
product smell tast largest driver consum
repurchas decis versu price
sophist flavor fragranc product
continu increas consum demand less sugar fat
salt will sacrific tast typic
custom retain intern flavor fragranc
sole supplier custom flavor fragranc solut
full life cycl given product
deepli ingrain suppli chain custom
serv key supplier
manufactur
well-establish brand well develop effort
new product maintain control
associ intellectu properti key distinct
separ less moati ingredi supplier
dynam endow price power convers
no-moat ingredi compani coverag offer
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
commodit bulk ingredi price key
purchas criterion appli main
intern flavor fragranc gener
rel wide econom profit spread year
past decad forecast return invest capit
rel flat explicit forecast period
high degre confid posit econom
profit prove durabl least next year
modestli compani cost capit
although might appear modest econom profit
spread wide-moat compani note financi
result stabl major profit swing unlik
assign stabl moat trend intern flavor
fragranc dont expect compani moat sourc
switch cost intang asset strengthen
weaken year come
earn posit moat trend would need establish
even better record prescienc identifi key
consum trend turn consist beat peer
market servic trend proprietari
solut time could fortifi compani
switch cost intang asset portfolio howev
would requir signific invest leav littl room
error execut standpoint neg moat
trend would potenti stem heighten regul
regard disclosur formul ingredi
use food beverag person care industri
valu intellectu properti could erod
time competitor becom readili abl emul
compani once-uniqu offer dont view either
outcom like therefor feel comfort
stabl moat trend rate
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oiff among moatiest profit
compani within broader ingredi suppli
oth compani overpaid acquir frutarom
secur unfavor term propos merger
dupont nutrit bioscienc busi
oth compani well posit capit
growth develop market gener
sale
ointegr frutarom prove challeng perhap
weigh companywid profit
oiff high spend sale act
barrier entri underpin innov promot
oiff high share sale develop market
roughli bring increas volatil exposur
currenc countri geopolit risk
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
intern flavor fragranc close net
debt/ebitda ratio time well trail
averag time believ fall
long term solid free cash flow persist
manag put share-repurchas program hold
order de-lever manag target reduct
metric time end
object prove achiev frutarom
acquisit consumm
year
manag advertis goal attain
billion addit revenu acquisit
year-end compani polici acquisit
chang great deal time tradit
undertak mani acquisit least none
larg enough figur investor radar screen
recent major acquisit complet
howev manag pursu deal sinc
frutarom larg deal
announc merger dupont nutrit bioscienc
busi yet great deal larger iff pension
postemploy benefit liabil modest
requir major cash outflow come year
forecast intern flavor fragranc
continu gener healthi free cash flow
consist done past decad
assign low uncertainti rate intern flavor
 fragranc compani cash flow gener quit
stabl revenu cyclic low financi leverag
prove manag even sizabl frutarom
deal well propos combin dupont
nutrit bioscienc busi consist free cash
flow gener allow
fragranc maintain strong financi condit
capit value-accret tuck-in opportun
manag turnov high past year
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
could lead instabl associ dysfunct
howev intern flavor fragranc appear
cope quit well previou transit period
board abl find replac key post
like ceo cfo
intern flavor fragranc highli
acquisit compani skill integr acquisit
test full
undertook acquisit big enough featur
investor radar undertaken sinc small
enough endang compani overal
stabil longer case howev
transform acquisit frutarom
complet octob integr frutarom
repres sourc uncertainti frutarom
right highli acquisit recent year
requir integr wide varieti product line
merger dupont nutrit bioscienc busi
announc deal come consider
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
ceo/chairman board/
assign poor stewardship rate intern flavor
 fragranc compani seen fair share
manag turnov recent year stark contrast
manag stabil largest peer andrea fibig
fourth ceo sinc helm sinc
septemb compani sinc
also current chairman board dynam
typic frown upon govern perspect fibig
background directli pertain core oper
previous work
bayer healthcar
pharmaceut
repres date owner name posit common share held report holder issuer
american fund invmt co amer
capit research manag compani
share
fund
share
fund
decemb rustom jilla name cfo
replac prior cfo rich leari jilla fourth
cfo sinc leari previous replac alison
cornel octob cornel left one year
job jilla offer year financi manag
experi prior new post jilla serv cfo
msc
equip distributor also cfo demat
group ansel limit
asid fibig dual role ceo chairman corpor
govern satisfactori eleven board member
independ board member elect
term one year mean whole board could
chang annual sharehold desir
histor exhibit avers although
chang significantli recent year
acquisit frutarom propos merger
dupont nutrit bioscienc busi manag
exceed target drive increment million
billion inorgan revenu end via
octob acquisit frutarom
skeptic goal howev question
decis public concret target view
like reduc compani bargain power might
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
press manag consumm deal without
suffici margin safeti ensur valu creation
contend overpaid frutarom deal
prove value-destruct sharehold addit
announc august discov improp
payment made custom frutarom
oper russia ukrain particularli concern
fact key member frutarom senior
manag time awar payment
addit misconduct subsequ uncov
although involv frutarom senior manag
rais concern improp payment might
widespread also contend merger
dupont nutrit bioscienc busi prove
value-destruct sharehold amid quit lofti synergi
execut pay tie perform annual
incent plan pay-out depend five indic local
work capit
individu perform
respect weight
four indic individu
perform ad februari
weight criteria subsequ chang
long-term incent plan paid cash share
depend econom profit total sharehold
return rel measur total period
three year variabl pay account roughli three
fourth main execut total pay highlight
strong emphasi perform compens
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
lower fair valu reflect advers
updat valuat model intern
flavor fragranc sensient technolog reflect
impact outbreak lower
fair valu estim fair valu estim fall
per share sensient fair valu
estim fall per share compani
fair valu reduct stem temper near-term
profit expect well downward adjust
assum termin ev/ebitda multipl clear
downward multipl adjust entir unrel
outbreak admittedli like overdu
although retain wide moat sensient maintain
narrow moat compani moat appear
narrow recent year
even market appear sour
compani prospect far current
share price stock offer attract risk-adjust
upsid updat fair valu estim trade
star territori sensient territori although
neither immun advers impact
outbreak contend insul
compani cover due healthi exposur custom
consum stapl sector addit
compani combin switch cost intang
asset decreas
likelihood cash-strap
custom abl switch cheaper altern
inde would risk
percept product
less favor long-term outlook stem
view frutarom integr partial dilut
moati firm legaci asset base furthermor
frutarom asset perform far wors iff
manag team expect accordingli
believ iff termin ev/ebitda multipl belong
peer givaudan symris weve lower
time howev reassess
compani econom moat rate integr
dupont nutrit bioscienc divis near although
asset appear moati
estim indic overpaid acquir
assert overpaid acquir frutarom
restructur
weve decreas sensient termin multipl time
engag major restructur effort
oper short optim effort indic
less competitively-advantag portfolio
previous assum fact base case assumpt
reflect return invest capit includ goodwil
slightli compani cost capit
case howev expect compani
restor econom profit gener rel wide
margin safeti cours explicit forecast
fve unchang given mix
share trade modestli lower compani
fourth-quart earn releas howev per
share fair valu estim unchang wide-moat
rate also remain intact although plan review
econom moat rate compani propos merger
dupont nutrit bioscienc unit close
expect earli
although fair valu estim unchang
due two offset factor assum equiti valu
current oper actual rose due time valu
money effect howev make share
transfer dupont sharehold part propos
transact valuabl therebi make deal
value-destruct
sharehold
previous assum therefor updat
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
valuat model would modestli increas fair
valu isol benefit fulli off-set
enterpris adjust includ account
implic dupont transact
side coin dynam benefici
dupont sharehold combin
entiti assum transact becom value-
accret equiti valu legaci
result mix companywid currenc neutral sale
growth healthi prior year period howev
companywid adjust oper margin roughli flat
year year remain concern perform
recent acquir frutarom asset
struggl deliv revenu growth organ basi
continu view overvalu share trade
territori although dupont deal might turn
success frutarom acquisit
thu far would requir realiz appear
highli optimist synergi target
bioscienc appear value-destruct
specul merger dupont nutrit
bioscienc busi
fragranc formal announc term appear
unfavor sharehold updat
valuat model account deal expect
close earli fair valu estim fall
per share wide moat rate
unchang although transform deal trigger
review close
strateg qualm combin
asset dupont nutrit bioscienc
busi overlap two portfolio
much play assum
probabl deal close well signific cut
appli propos synergi target
conclus merger prove value-destruct
sharehold lie pure notion appear
overpay otherwis attract group asset
research indic sharehold effect
pay time presynergi multipl time
multipl includ synergi assumpt
analysi would impli time multipl compani
achiev lofti synergi target full
although fear dupont asset would command
even higher multipl amid report bid war
kerri group announc term still repres
steep price base prevail valuat asset
express dupont model
analyz deal term assum downward
enterpris valu adjust million model
equat roughli per share market
respond punit share fell per share
deal announc declin share
trade modestli updat fair valu
still territori time
review assumpt dupont nutrit
bioscienc busi ascrib enterpris valu
billion underli asset addit
assum combin compani achiev
propos cost synergi none revenu synergi
present valu futur synergi provid anoth
billion valu howev account present
valu agreed-on billion payment dupont
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
deal complet math longer add
sharehold combin
compani worth lower special payment
roughli billion would made value-neutr
leav
come surpris assumpt relat
propos synergi target massiv impact
result valuat conclus exampl
assum compani achiev cost synergi
target rather roughli two third base case
none revenu synergi target model instead
reflect million valu destruct
give credit achiev cost revenu
synergi look past idea revenu synergi tend
much dubiou cost synergi model
would suggest roughli million valu creation
topic remiss highlight fact
acquisit frutarom continu prove quit
challeng inde steep sell-off today share
like reflect market particip will give
board manag team benefit doubt
far larger transact already-
team argu propos synergi frutarom
larg met exceed perform
underli asset simpli fallen well shi expect
addit integr process reveal
legaci frutarom busi made improp payment
russia ukrain unpleas discoveri perhap
could avoid closer scrutini due
argument could also made frutarom appear
ripe synergi realiz dupont asset
frutarom effect roll-up numer smaller
busi would theoret benefit
establish playbook best practic provid
wherea dupont asset like alreadi oper
effici counterpoint could perhap
endless march tax-effici dupont whole
left nutrit bioscienc unit state flux
hinder progress toward cost-cut
deal expect establish pro forma net leverag
time net debt/ebitda sit well
typic comfort zone believ leverag
magnitud problemat believ compani
troubl achiev target reduc net
leverag time within two year deal
close deal expect close end
first quarter look forward monitor
 flavor fragranc share lower potenti
dec bloomberg report rumor
flavor fragranc explor combin
dupont nutrit busi news
specul point dupont valuat
model unchang maintain per share fair
valu estim wide-moat rate well
per share fair valu estim narrow-moat rate
dupont
reportedli kerri group express
interest dupont nutrit asset overal size
busi play high qualiti underli
asset exhibit clear trace switch cost
intang asset combin potenti bid
war like set lofti price tag
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
clearli saw caus optim one key factor drive
share higher manag announc
review improp payment frutarom made russia
ukrain indic addit find
previous divulg secondari review high
risk jurisdict provid caus addit concern
end improp payment impact less
frutarom combin sale
forecast million adjust oper
incom billion revenu adjust
oper margin although outlook reflect modest
margin contract prior year continu
forecast slow steadi margin expans ahead
mid-cycle adjust oper margin forecast
expect frutarom integr broader
firm-wide product program gradual bear fruit
although manag laid normal organ
growth rate expect earn releas
reflect concern
prevail headwind pressur top-lin growth
multi-national cpg custom set prove difficult
overcom accordingli even though expect modest
margin expans take hold see reason believ
profit enjoy seismic shift upsid
hous dupont nutrit asset well
bidder asset would spun exist investor
tax-effici transact remain seen
portion dupont nutrit bioscienc segment
would ultim involv deal howev given
trade multipl competitor surmis
segment whole would command multipl safe
time ebitda rang time trail ebitda
would suggest segment valuat rang
billion howev estim price rang
nutrit busi alon would roughli two third
dupont nutrit busi overlap exist
busi line also offer new adjac
howev share trade nearli lower
news still digest acquisit frutarom
consumm octob news potenti
much larger deal dupont come surpris
investor caution reflect today downward share price
movement understand on-going integr
frutarom far seamless
littl caus encourag
third-quart earn releas organ revenu
growth remain pressur adjust oper margin
contract prior year period updat
valuat model fair valu estim wide moat
rate unchang although highlight attract
entri point share sell-off stem
firm lacklust second-quart earn releas
share trade roughli line fair valu
given today ralli share market particip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
